Graves Disease
A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
Subtype terms (1)
More specific conditions that are subtypes of Graves Disease in the MeSH hierarchy.
- Graves Ophthalmopathy
69 drugs (42 approved, 27 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (11)
Phase 2 trials (12)
Phase 1 trials (4)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (9)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (9)